Dectrekumab

DB14789InvestigationalProtein Based Therapies

Dectrekumab is under investigation in clinical trial NCT00987545 (Efficacy 2 Part Study of Identification of Keloid Biomarkers and Effect of QAX576 on Keloid Recurrence).

Mechanism: Pharmacologically active on Interleukin-13
Curator reviewed
Code names: QAX576

Resolves to

Compound

UNII764HZ2554DCAS1528523-94-5

Targets

P35225IL13

What you can answer from here — as of July 07, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

13Clinical trialsPhase, status and sponsor resolved per trial

5+ReferencesStructured and connected to the statements they support

Which drugs share a target with Dectrekumab, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account